What are the effects of corticosteroids on triglyceride levels?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: May 8, 2025 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

From the Guidelines

Steroids, particularly corticosteroids, can significantly increase triglyceride levels in the blood, and their use should be carefully managed to minimize this risk, especially in patients with pre-existing high triglycerides or cardiovascular risk factors. When taken systemically (orally or intravenously), medications like prednisone, dexamethasone, and methylprednisolone typically raise triglycerides by altering how the body processes fats. This effect is dose-dependent and usually more pronounced with higher doses (such as prednisone doses above 10-20mg daily) and longer treatment durations (beyond 1-2 weeks) 1. The mechanism involves increased liver production of very low-density lipoproteins (VLDL), reduced clearance of triglycerides from the bloodstream, and insulin resistance that further disrupts fat metabolism.

Key Considerations

  • Patients taking steroids should have their lipid levels monitored regularly, especially those with pre-existing high triglycerides or cardiovascular risk factors.
  • Lifestyle modifications including a low-fat diet, regular exercise, and limiting alcohol consumption can help mitigate steroid-induced triglyceride elevations during necessary treatment 2.
  • According to the 2021 ACC expert consensus decision pathway, combined physical activity and weight loss can result in up to a 20% reduction in triglycerides, with moderate physical activity and a 5% to 10% body weight reduction being recommended 2.
  • The current recommendation for physical activity for adults is to engage in at least 150 minutes per week of accumulated moderate-intensity or 75 minutes per week of vigorous-intensity aerobic physical activity to reduce ASCVD risk 2.

Management Strategies

  • Initial treatment of patients with mild to moderate hypertriglyceridemia should include dietary counseling and weight loss in patients who are overweight or obese 3.
  • For patients with severe to very severe hypertriglyceridemia, reduced intake of dietary fat and simple carbohydrates is recommended, in combination with drug treatment to reduce the risk of pancreatitis 3.
  • Fibrates are the first-line treatment in patients with hypertriglyceridemia who are at risk of pancreatitis, while statins have a modest triglyceride-lowering effect and may be useful to modify cardiovascular risk in patients with moderately elevated triglyceride levels 1.

From the Research

Effects of Steroids on Triglycerides

There is no direct evidence in the provided studies regarding the effects of steroids on triglycerides.

Alternative Factors Affecting Triglycerides

  • Hypertriglyceridemia is a common condition that affects approximately 33% of the US population 4
  • Elevated triglyceride levels are independently associated with cardiovascular disease (CVD) risk, and severe hypertriglyceridemia is a risk factor for acute pancreatitis 4, 5
  • Statins are the first line of therapy for managing mild to moderate hypertriglyceridemia, but may not be sufficient for individuals with severe hypertriglyceridemia 4
  • Other treatments such as fibrates, niacin, and long-chain omega-3 fatty acids may be effective in reducing triglyceride levels 4, 6, 7
  • Dietary modification and weight reduction are also important elements in managing hypertriglyceridemia 8

Treatment Options for Hypertriglyceridemia

  • Statin therapy is a foundational pharmacologic care for atherosclerotic cardiovascular disease (ASCVD) event risk reduction 8
  • Novel therapies such as icosapent ethyl (IPE) and treatments targeting PPAR-ɑ, ApoC-III, and AngPTL3 may be effective in reducing triglyceride levels and ASCVD risk 8
  • Omega-3 fatty acids, particularly EPA, may have a role in reducing ASCVD risk and managing hypertriglyceridemia 8, 7

Related Questions

How often should a lipid panel be repeated for a patient with severely elevated triglycerides (hypertriglyceridemia)?
Can Chronic Lymphocytic Leukemia (CLL) cause hypertriglyceridemia?
For a 50-year-old man with normal LDL cholesterol, borderline low HDL cholesterol, triglycerides of 300 mg/dL, and already on maximum-dose statin therapy, which is the most appropriate next step: add a statin, omega‑3 fatty acids, niacin, or clofibrate?
What dietary and lifestyle recommendations should be made for a 61‑year‑old woman with asymptomatic hypertriglyceridemia (triglyceride level 450 mg/dL), total cholesterol 250 mg/dL, HDL 232 mg/dL, LDL 120 mg/dL, hemoglobin A1c 5.6%, normal renal function, BMI 24, seasonal allergies, chronic low‑back pain, and current use of loratadine and ibuprofen as needed?
In a 37-year-old obese patient with a 7% atherosclerotic cardiovascular disease (ASCVD) risk, no diabetes, low-density lipoprotein cholesterol (LDL-C) of 91 mg/dL and triglycerides of 707 mg/dL, what is the best next step after lifestyle modification and omega-3 supplementation?
Which has higher Insulin-like Growth Factor 1 (IGF-1) levels, cheese or milk?
What is the recommended time window for administering the 2nd Hepatitis B (Hep B) vaccine?
Will a Computed Tomography (CT) scan show Pelvic Inflammatory Disease (PID)?
What is the dosing for Ceftriaxone (Rocephin) for community-acquired pneumonia (CAP)?
What is the recommended frequency for monitoring Complete Blood Count (CBC) in a patient on Tegretol (Carbamazepine)?
What does low Complement 4 (C4) with normal Complement 3 (C3) indicate in an adolescent patient with oligoarticular Juvenile Idiopathic Arthritis (JIA)?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.